In addition, there was a nonsignificant trend of a lower rate of adverse outcomes in the PCT group at 1-month follow-up (difference −1.5%, 95% CI: −4.6–1.7%).
← all excerpts
Was the implementation strategy of the ProACT trial adequately proactive?
1
—
—